The emergence of mephedrone along with other artificial cathinones has presented worries for lawmakers and regulatory organizations tasked with controlling the proliferation of latest psychoactive substances. The dynamic character of artificial drug creation, coupled with the flexibility of chemists to switch molecular structures to evade authorize… Read More